Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  ormaplatin
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-6 of 6 for your search:
Start Over
Phase I Trial of Tetraplatin Administered Daily for Five Consecutive Days Every 28 Days in Patients with Metastatic Cancer (Summary Last Modified 02/91)
Phase: Phase I
Type: Treatment
Status: Closed
Age: over 18
Sponsor: NCI
Protocol IDs: UTHSC-8905011149, NCI-T89-0234C, T89-0234
Phase I Trial of Tetraplatin in Patients with Solid Tumors and Lymphomas (Summary Last Modified 12/90)
Phase: Phase I
Type: Treatment
Status: Completed
Age: over 18
Sponsor: NCI
Protocol IDs: NCI-90-C-129A, WRAMC-9010, NCI-T90-0014N, T90-0014
Phase I Study of Tetraplatin in Patients with Advanced Cancer (Summary Last Modified 09/91)
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: WCCC-CO-9092, NCI-T90-0052C, T90-0052
Phase I Study of Tetraplatin in Patients with Advanced Solid Tumors (Summary Last Modified 07/91)
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: FCCC-91013, NCI-T90-0224D, T90-0224
Phase I Study of Tetraplatin Administered as a 30-Minute Daily Infusion for 5 Days in Patients with Advanced Cancer (Summary Last Modified 08/91)
Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: DU-ET-9102, NCI-T91-0043D, T91-0043
Phase I Trial of Intraperitoneal Tetraplatin in Patients with Malignancies Involving the Peritoneal Cavity (Summary Last Modified 08/93)
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: UCSD-91285, NCI-T91-0111D, T91-0111
Start Over